# NeuroPace Inc (NPCE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from NeuroPace Inc's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NPCE/mda/fy2025/): filed 2026-03-03; accession 0001528287-26-000011 (https://www.sec.gov/Archives/edgar/data/1528287/000152828726000011/npce-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NPCE/mda/fy2024/): filed 2025-03-04; accession 0001528287-25-000007 (https://www.sec.gov/Archives/edgar/data/1528287/000152828725000007/npce-20241231.htm)
- [FY 2023 MD&A](/company/NPCE/mda/fy2023/): filed 2024-03-05; accession 0001528287-24-000005 (https://www.sec.gov/Archives/edgar/data/1528287/000152828724000005/npce-20231231.htm)
- [FY 2022 MD&A](/company/NPCE/mda/fy2022/): filed 2023-03-02; accession 0001528287-23-000007 (https://www.sec.gov/Archives/edgar/data/1528287/000152828723000007/npce-20221231.htm)
- [FY 2021 MD&A](/company/NPCE/mda/fy2021/): filed 2022-03-10; accession 0001528287-22-000006 (https://www.sec.gov/Archives/edgar/data/1528287/000152828722000006/npce-20211231.htm)

Back to /company/NPCE/